相关实验视频

Updated: Jun 16, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

药物诱导的替代拼接模块用于心脏中可调节的向量表达

Zhan Chen^1,2, Luzi Yang^1,2, Yueyang Zhang^1,2

¹Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Nature cardiovascular research

|June 13, 2025

概括

一个名为DreAM的新系统允许精确控制使用药物risdiplam的腺相关病毒 (AAV) 基因治疗表达. 这提高了基因治疗的安全性和有效性,特别是在心脏再生方面.

科学领域:

生物技术是生物技术.
基因治疗基因治疗
分子生物学分子生物学

背景情况:

腺相关病毒 (AAV) 对基因疗法至关重要,但缺乏微调表达的方法,限制了临床应用.
目前的基因治疗方法在控制治疗性蛋白质水平方面面临挑战,这会影响安全性和有效性.

研究的目的:

开发一种新的药物诱导系统,精确控制AAV介导的基因表达.
提高AAV基因疗法的安全性,疗效和治疗范围.

主要方法:

开发了药物诱导的替代拼接模块 (DreAM),对risdiplam有反应.
将DreAM集成到针对心肌细胞 (AAV9-Tnnt2-miR122TS) 的AAV9载体中,用于YAP5SA输送.
评估了DreAM在体内对基因表达的剂量依赖,时间,可逆和可重复的控制.

主要成果:

里斯迪普拉姆激活了DreAM调节的AAV表达,具有2,000倍的诱导,证明了剂量依赖性和器官特异性.
DreAM允许暂时,可逆和可重复的基因表达控制,具有2天的时间分辨率.
在心肌梗塞模型中通过短暂的YAP5SA激活成功进行心脏再生,降低死亡率和非目标效应.

结论:

DreAM提供了一种临床相关的方法来调节AAV表达,改善基因疗法控制.
该系统通过能够精确地控制基因传递的时间和空间来提高治疗效率和安全性.
DreAM对于推进基因疗法应用,特别是再生医学,具有显著的潜力.

更多相关视频

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

相关概念视频

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

RNA Splicing

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...